Bristol-Myers Squibb Rights
CELG.RT
21 hedge funds and large institutions have $5.2M invested in Bristol-Myers Squibb Rights in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
982% more capital inflows, than outflows
Capital inflows: $3.94K | Capital outflows: $364
17% more funds holding
Funds holding: 18 → 21 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.02% → 0.03% (+0%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.98K |
| 2 |
Two Sigma Securities
New York
|
+$626 |
| 3 |
Trivium Point Advisory
Westport,
Connecticut
|
+$397 |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$144 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$349 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$13 |
| 3 |
Morgan Stanley
New York
|
-$2 |
CELG.RT Hedge Fund Activity: Q3 2024 in Review
21 of the 6,985 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q3 2024, worth a combined $5.2M — up 25% from $4.17M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CELG.RT positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Bank of America, adding an estimated $1.98K. The largest seller was Susquehanna International Group, cutting an estimated $349.
- 21 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q3 2024, up from 18 in Q2 2024.
- Funds reported $5.2M of Bristol-Myers Squibb Rights stock for Q3 2024, up 25% quarter-over-quarter.
- 3 funds opened new Bristol-Myers Squibb Rights positions in Q3 2024 and 0 closed out, a net change of +3 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q3 2024 was Bank of America, an estimated $1.98K added.
- The largest Bristol-Myers Squibb Rights seller in Q3 2024 was Susquehanna International Group, an estimated $349 sold.
Based on aggregated 13F filings for Q3 2024.